EMA — authorised 6 July 2017
- Marketing authorisation holder: Dompe farmaceutici s.p.a.
- Status: approved
🇪🇺 Oxervate in European Union
EMA authorised Oxervate on 6 July 2017
Marketing authorisation
Oxervate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Oxervate approved in European Union?
Yes. EMA authorised it on 6 July 2017.
Who is the marketing authorisation holder for Oxervate in European Union?
Dompe farmaceutici s.p.a. holds the EU marketing authorisation.